| 產(chǎn)品名稱 | TG 101348 - Fedratinib | SAR 302503 |
| 產(chǎn)品貨號 | Axon 1588 CAS [936091-26-8] MF C27H36N6O3SMW 524.68 Purity: 99% Soluble in DMSO Description An orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 (JAK2, IC50: ca 3 nM) with potential antineoplastic activity. KEYWORDS:?TG 101348 | supplier | JAK2 inhibitor | Fedratinib | SAR 302503 | TG101348 | SAR302503 | TG-101348 | SAR-302503 | CAS [936091-26-8] | JAK-STAT Pathway | Janus-associated kinase | antineoplastic | hematopoietic stem cell | HSC |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
TG 101348 - Fedratinib | SAR 302503Axon 1588 CAS [936091-26-8] MF C27H36N6O3S
DescriptionAn orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 (JAK2, IC50: ca 3 nM) with potential antineoplastic activity. KEYWORDS:?TG 101348 | supplier | JAK2 inhibitor | Fedratinib | SAR 302503 | TG101348 | SAR302503 | TG-101348 | SAR-302503 | CAS [936091-26-8] | JAK-STAT Pathway | Janus-associated kinase | antineoplastic | hematopoietic stem cell | HSC ? List of publications using TG 101348 (Axon 1588) purchased from Axon Medchem
JAK2 inhibitor
Chemical nameN-tert-butyl-3-(5-methyl-2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-ylamino)benzenesulfonamide Parent CAS No.[936091-26-8] |
| 產(chǎn)品資料 |
